|09-10-2018 04:55 PM CET - Health & Medicine||
PDX Models Market Business Opportunities, Current Trends, Market Challenges & Global Industry Analysis & Forecast by 2025: The Jackson Laboratory, Champions Oncology, Inc., Oncodesign, WuXi AppTec, Charles River Laboratories, Crown Bioscience, Inc., Horiz
Press release from: Data Bridge Market Research
There are several recent developments, product launches, joint ventures, merges and accusations by the key market players and brands who will dominate the PDX Models market and hence Healthcare IT industry for the forecast years 2018 to 2025.
This report has all the company profiles for the top players and brands and along with that the report also contains a synopsis of market definition, classifications, applications and market trends, and the PDX Models market drivers and restrains that are derived from a well know method called SWOT analysis.
Looking for more information on this market? Get Free sample report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...
Global PDX models market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Covered in this report
The report covers the present scenario and the growth prospects of the global PDX models market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Top key players
• Crown Bioscience Inc.
• The Jackson Laboratory
• Champion Oncology, Inc.
• Charles River
• Wuxi AppTec
• Horizon Discovery Group plc
• Pharmatest Services
• Hera Biolabs
• EPO Berlin-Buch GmbH
• Creative Animodel
• MI Bioresearch Inc
• Aragen Bioscience
Browse Detailed TOC, Tables and Figures @ databridgemarketresearch.com/toc/?dbmr=global-pdx-models-...
Drivers: Global PDX Models Market
Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.
RISING NUMBER OF PHARMACEUTICAL R&D ACTIVITIES IN CANCER RESEARCH
Cancer is the second most death causing disease in people around the world. According to the study by WHO, there were almost 8.8 million deaths noted due to the cancer in the year 2015 globally. In low- and middle-income countries, 70.0% of deaths are due to cancer. Due to rising cancer prevalence worldwide, the healthcare sector and organizations (both public and private) are investing huge amount of money to carry out various scientific researches to develop novel drugs and technology to treat disease.
Government bodies across are investing heavily in research activities for advancements in the field of cancer across the globe. Biotech and pharma companies are accelerating drug development activities in the oncology sector. According to the International Federation of Pharmaceutical Manufacturers & Associations key facts 2017, pharmaceutical industry currently spends over USD 149.8 Billion on R&D activities per year.
Patient Derived Xenograft (PDX) models are majorly used by pharmaceutical and biotechnology companies as models for oncology research. These models provide various aspects of genesis, progression, and clinical course of human cancers. PDX models are generated by transplanting fresh human tumor specimen from a cancer patient into a mouse or rat. Therefore, these models give near accurate assessment of human tumor biology, identification of therapeutic targets, preclinical screening, and evaluation of drugs for various cancers.
According to the article published by THE JACKSON LABORATORY, cancer research is going to get help in improving data sharing and reproducibility. This will be possible through the new minimal information standard for Patient Derived Xenograft (PDX) models, which will make the models easy to find, access, integrate and reuse which are highly used in research.
THE JACKSON LABORATORY is also spending in R&D programs. In 2017, they tripled their investments from previous year. Below mentioned are the investment stats for the amount spent by the company for new research and development.
In 2017, Oncodesign (France), which is a biopharma company dedicated to the precision medicine, invested around 16.15 million USD in 2017 for the research and development activities, which was almost double investment from the previous year.
Based on geography, the market is segmented into 5 geographical regions:
• North America
• South America
• Middle East and Africa
Is there any query or specific requirements? Ask to our Industry Expert @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...
TABLE OF CONTENTS GLOBAL PDX MODELS MARKET
2 MARKET SEGMENTATION
3 MARKET OVERVIEW
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL PDX MODELS MARKET, BY TYPE
6.2 MICE MODELS
6.3 RAT MODELS
7 GLOBAL PDX MODELS MARKET, BY TUMOR TYPE
7.2 GASTROINTESTINAL TUMOR MODELS
7.3 GYNECOLOGICAL TUMOR MODELS
7.4 RESPIRATORY TUMOR MODELS
7.5 UROLOGICAL TUMOR MODELS
7.6 HEMATOLOGICAL TUMOR MODELS
8 GLOBAL PDX MODELS MARKET, BY APPLICATION
8.2 PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH
8.3 BIOMARKER ANALYSIS
9 GLOBAL PDX MODELS MARKET, BY END USER
9.2 CONTRACT RESEARCH ORGANIZATIONS
9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.4 ACADEMIC AND RESEARCH INSTITUTIONS
10 GLOBAL PDX MODELS MARKET, BY GEOGRAPHY
10.2 NORTH AMERICA
10.4 ASIA PACIFIC
10.5 SOUTH AMERICA
10.6 MIDDLE EAST AND AFRICA
11 GLOBAL PDX MODELS MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC
12 COMPANY PROFILES
12.1 CHARLES RIVER
12.2 CROWN BIOSCIENCE INC. (SUBSIDIARY OF JSR CORPORATION)
12.3 CHAMPION ONCOLOGY, INC
12.4 ARAGEN BIOSCIENCE (SUBSIDIARY OF GVK BIOSCIENCES PRIVATE LIMITED)
12.5 CREATIVE ANIMODEL
12.6 EPO BERLIN-BUCH GMBH
12.8 HERA BIOLABS
12.9 HORIZON DISCOVERY GROUP PLC
13 RELATED REPORTS
Looking for more insights from this report? click the link below @ databridgemarketresearch.com/reports/global-pdx-models-ma...
North America Healthcare IT Outsourcing Market -Industry Trends and Forecast to 2024
North America Healthcare IT Outsourcing Market By Product Type (Provider (EHR, PIS, LIS, RIS, PACS, RCM, Others), Payer (Customer Management Systems, Claim Processing, Fraud Detection, Others), Life Sciences HCIT (CTMS, CDMS, ERP, Others), Operational HCIT (SCM, Business Process Outsourcing), HCIT Infrastructure (Cloud Services, Management Services)), By End User (Provider, Payer, Pharma & Biotech, Clinical Research Organization, Others), By Country (U.S., Canada, Mexico) –Industry Trends and Forecast to 2024
Report Access: databridgemarketresearch.com/reports/north-america-health...
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
This release was published on openPR.
News-ID: 1230901 • Views: 420More releases